Typical lung carcinoid tumor with ACTH-paraneoplastic syndrome: A case report

Background. Neuroendocrine tumors associated with ACTH-ectopic secretion are rare, and pose a diagnostic challenge due to varied symptoms, leading to delayed treatment. In addition, the presence of ectopic Cushing syndrome significantly increases the risk of metabolic, infectious and surgical complications, but surgery remains the primary and curative treatment for these patients. aim of study: to improve the treatment outcomes of patients with neuroendocrine lung tumors associated with ACTH-paraneoplastic syndrome.

Case presentation. A 65-year-old female patient presented to the Kommunarka Medical and Clinical Center with neuroendocrine lung tumor associated with ACTH-ectopic syndrome. The patient underwent a comprehensive laboratory and instrumental examinations to assess the extent of the tumor, functional status, hormonal profile, and to differentiate between ACTH-dependent and ACTH-independent hypercorticism. The patient underwent thoracoscopic lobectomy. In the postoperative period, there was a regression of the clinical and serological manifestations of the ACTH-ectopic syndrome. Histological and immunohistochemical examinations of surgical specimen confirmed the diagnosis of typical lung carcinoid.

Conclusion. This case report and literature analysis demonstrate challenges in diagnosing lung carcinoid tumors, the need for a polyvalent approach, preoperative correction of endocrine disorders, and radical surgery, which provides the best prognosis.

1. Thoracic tumors. WHO Classification of Tumors 5th Edition. Vol. 5. 2021. WHO classification of tumors Editorial Board. ISBN: 978-92-8324506-3.

2. Moiseenko F.V., Artamonova E.V., Gorbunova V.A., Delektorskaya V.V., Lyubimova N.V., Markovich A.A., Orlov S.V. Neuroendocrine neoplasias of the lungs and thymus. Malignant tumors. 2024; 14(3S2-1(1)): 130–45. (in Russian). doi: 10.18027/2224-50572024-14-3s2-1.1-07. EDN: JDWBFU.

3. Travis WD. Lung tumours with neuroendocrine differentiation. Eur J Cancer. 2009; 45 (s1): 251–66. doi: 10.1016/S0959-8049(09)70040-1.

4. Halperin D.M., Shen C., Dasari A., Xu Y., Chu Y., Zhou S., Shih Y.T., Yao J.C. Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study. Lancet Oncol. 2017; 18(4): 525–34. doi: 10.1016/S1470-2045(17)30110-9.

5. La Rosa S., Volante M., Uccella S., Maragliano R., Rapa I., Rotolo N., Inzani F., Siciliani A., Granone P., Rindi G., Dominioni L., Capella C., Papotti M., Sessa F., Imperatori A. ACTH-producing tumorlets and carcinoids of the lung: clinico-pathologic study of 63 cases and review of the literature. Virchows Arch. 2019; 475(5): 587–97. doi: 10.1007/s00428-019-02612-x.

6. Brown W. Hurst. A case of pluriglandular syndrome: “diabetes of bearded women”. The Lancet. 1928; 212(5490): 1022–23.

7. Liddle G.W., Nicholson W.E., Island D.P., Orth D.N., Abe K., Lowder S.C. Clinical and laboratory studies of ectopic humoral syndromes. Recent Prog Horm Res. 1969; 25: 283–314. doi: 10.1016/b978-0-12571125-8.50009-0.

8. Aniszewski J.P., Young W.F. Jr., Thompson G.B., Grant C.S., van Heerden J.A. Cushing syndrome due to ectopic adrenocorticotropic hormone secretion. World J Surg. 2001; 25(7): 934–40. doi: 10.1007/s00268-001-0032-5.

9. Golounina O.O., Belaya Zh.E., Rozhinskaya L.Ya., Marova E.I., Pikunov M.Yu., Khandaeva P.M., Arapova S.D., Dzeranova L.K., Kuznetsov N.S., Fadeev V.V., Melnichenko G.A., Dedov I.I. Clinical and laboratory characteristics and results of treatment of patients with acth-producing neuroendocrine tumors of various localization. Therapeutic Archive. 2021; 93(10): 1171–78. (in Russian). doi: 10.26442/00403660.2021.10.201102. EDN: HLPRBG.

10. Gurevich L.E., Voronkova I.A., Marova E.I., Rozhinskaya L.Ya., Lapshina A.M., Britvin T.A., Komerdus I.V. Clinical and morphological characteristic of acth producing tumors of various localization and the ectopic cushing’s syndrome. Almanac of Clinical Medicine. 2017; 45(4): 289–301. (in Russian). doi: 10.18786/2072-0505 -2017-45-4-289-301. EDN: ZCQUZB.

11. Savu C., Melinte A., Lukadi J.L., Mirvald C., Savu C., Belu E., Diaconu C., Iliescu L., Balescu I., Stiru O., Bratu O., Gorecki G., Bacalbasa N. Neuroendocrine syndrome in bronchial carcinoid tumors. Exp Ther Med. 2020; 20(6): 200. doi: 10.3892/etm.2020.9330.

12. Golounina O.O., Slashchuk K.Yu., Khairieva A.V., Tarbaeva N.V., Degtyarev M.V., Belaya Zh.E. X-RAY and radionuclide imaging in the diagnosis of acth-producing neuroendocrine tumors. Medical Radiology and Radiation Safety. 2022; 67(4): 80–88. (in Russian). doi: 10.33266/10246177-2022-67-4-80-88. EDN: EJBWUD.

13. Melnichenko G.A., Dedov I.I., Belaya Zh.E., Rozhinskaya L.Ya., Vagapova G.R., Volkova N.I., Grigor’ev A.Yu., Grineva E.N., Marova E.I., Mkrtumayn A.M., Trunin Yu.Yu., Cherebillo V.Yu. Cushing’s disease: the clinical features, diagnostics, differential diagnostics, and methods of treatment. Problems of Endocrinology. 2015; 61(2): 55–77. (in Russian). doi: 10.14341/probl201561255-77. EDN: TXOBBL.

14. National comprehensive cancer network. NCCN Clinical Practice Guidelines in Oncology: neuroendocrine and adrenal tumors. Version 2.2025 [Internet]. [cited 20.11.2025]. URL: https://www.nccn.org/guidelines/.

15. Seastedt K.P., Alyateem G.A., Pittala K., Steinberg S.M., Schrump D.S., Nieman L.K., Hoang C.D. Characterization of Outcomes by Surgical Management of Lung Neuroendocrine Tumors Associated With Cushing Syndrome. JAMA Netw Open. 2021; 4(9): e2124739. doi: 10.1001/jamanetworkopen.2021.24739.

16. Golounina O.O., Belaya Zh.E., Rozhinskaya L.Ya., Pikunov M.Yu., Markovich A.A., Dzeranova L.K., Marova E.I., Kuznetsov N.S., Fadeev V.V., Melnichenko G.A., Dedov I.I. Survival predictors in patients with ectopic acth syndrome. Problems of Endocrinology. 2022; 68(6): 30–42. (in Russian). doi: 10.14341/probl13144. EDN: MAXNGB.

17. Davi’ M.V., Cosaro E., Piacentini S., Reimondo G., Albiger N., Arnaldi G., Faggiano A., Mantovani G., Fazio N., Piovesan A., Arvat E., Grimaldi F., Canu L., Mannelli M., Ambrogio A.G., Pecori Giraldi F., Martini C., Lania A., Albertelli M., Ferone D., Zatelli M.C., Campana D., Colao A., Scaroni C., Terzolo M., De Marinis L., Cingarlini S., Micciolo R., Francia G. Prognostic factors in ectopic Cushing’s syndrome due to neuroendocrine tumors: a multicenter study. Eur J Endocrinol. 2017; 176(4): 453–61. doi: 10.1530/EJE-16-0809.

18. Xu S., Li X., Ren F., He J., Zhao S., Wang Y., Ren D., Zhu S., Lei X., Chen G., Chen J. Sublobar Resection Versus Lobectomy for Early-Stage Pulmonary Carcinoid Tumors ≤3 cm in Size: A SEER Population-Based Study. Ann Surg. 2022; 276(6): e991–e999. doi: 10.1097/sLA.0000000000004593.

19. Shevchenko Ju.L., Ablicov Ju.A., Vasilashko V.I., Ablicov A.Ju., Orlov S.S., Malcev A.A., Marova E.I., Rozhinskaja L.Ja., Shhepetkova L.V., Belaja Zh.E., Plotnickij A.V. DIfficulties in the diagnosis and treatment of ectopic acth tumors. Bulletin of Pirogov National Medical & Surgical Center. 2013; 8(3): 25–29. (in Russian). EDN: RMUJYH.

20. Pikunov M., Savelyeva T., Belaya Zh., Buryakin S., Degtyarev M. Surgical treatment for the patient with ectopic acth syndrome caused by neuroendocrine lung tumor that became apparent 5 years after bilateral adrenalectomy: case report. Surgery Eastern Europe. 2022; 11(2): 207–14. (in Russian). doi: 10.34883/PI.2022.11.2.004. EDN: YFAWML.

21. Reuling E.M.B.P., Dickhoff C., Plaisier P.W., Bonjer H.J., Daniels J.M.A. Endobronchial and surgical treatment of pulmonary carcinoid tumors: A systematic literature review. Lung Cancer. 2019; 134: 85–95. doi: 10.1016/j.lungcan.2019.04.016.

22. Kneuertz P.J., Kamel M.K., Stiles B.M., Lee B.E., Rahouma M., Harrison S.W., Altorki N.K., Port J.L. Incidence and Prognostic Significance of Carcinoid Lymph Node Metastases. Ann Thorac Surg. 2018; 106(4): 981–88. doi: 10.1016/j.athoracsur.2018.05.044.

23. Vesterinen T., Mononen S., Salmenkivi K., Mustonen H., Räsänen J., Salo J.A., Ilonen I., Knuuttila A., Haglund C., Arola J. Clinicopathological indicators of survival among patients with pulmonary carcinoid tumor. Acta Oncol. 2018; 57(8): 1109–16. doi: 10.1080/0284186X.2018.1441543.